£1.5M
The pre-seed round was co-led by Kadmos Capital and Exceptional Ventures and will support the transition of designed drug combinations into wet-lab validation.
Big Picture Bio
AI-driven drug discovery platform designing optimal cancer combination therapies.
£1.5MTotal raised
Big Picture Bio develops AI-designed combination therapies for cancer and other complex diseases using a generative world model.
Categories
Founders
KP
Kerstin Papenfuss
CEO and co-founder
MH
Mark Hammond
CTO and co-founder